OÜ HagarexRegistered
Key figures
1 050 758 €+13,8%
Revenue 2025
+15,0%
Average annual growth 2019–2025
Ratios
2025−2,1%
Profit margin
5,6%
EBITDA margin
93,2%
Equity ratio
11×
Current ratio
−2,4%
Return on equity
871 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 585 138 € | 2 | 2323 € |
| Q1 2026 | 568 842 € | 2 | 2568 € |
| Q4 2025 | 479 400 € | 2 | 2634 € |
| Q3 2025 | 533 647 € | 2 | 2487 € |
| Q2 2025 | 460 082 € | 2 | 1828 € |
| Q1 2025 | 886 878 € | 2 | 1526 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Summary of financial statements2019–2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||
| Total current assets | 403 544 | 578 928 | 713 858 | 844 567 | 922 865 | 802 710 | 728 991 |
| Total non-current assets | 62 117 | 32 600 | 69 075 | 171 323 | 147 471 | 355 299 | 254 886 |
| Total assets | 465 661 | 611 528 | 782 933 | 1 015 890 | 1 070 336 | 1 158 009 | 983 877 |
| Balance sheet — liabilities and equity | |||||||
| Current liabilities | 9248 | 13 889 | 46 539 | 184 726 | 176 484 | 218 969 | 66 828 |
| Non-current liabilities | — | — | — | — | — | — | — |
| Total liabilities | 9248 | 13 889 | 46 539 | 184 726 | 176 484 | 218 969 | 66 828 |
| Share capital | 15 338 | 15 338 | 15 338 | 15 338 | 15 338 | 15 338 | 15 338 |
| Retained earnings of previous periods | 407 410 | 439 541 | 580 767 | 719 522 | 814 292 | 876 980 | 922 169 |
| Profit for the year | 32 131 | 141 226 | 138 755 | 94 770 | 62 688 | 45 188 | −21 992 |
| Reserves and other equity | 1534 | 1534 | 1534 | 1534 | 1534 | 1534 | 1534 |
| Total equity | 456 413 | 597 639 | 736 394 | 831 164 | 893 852 | 939 040 | 917 049 |
| Income statement | |||||||
| Sales revenue | 453 690 | 724 223 | 817 604 | 791 232 | 1 274 900 | 923 477 | 1 050 758 |
| Operating profit | 33 267 | 142 770 | 135 580 | 94 266 | 61 262 | 39 037 | −27 971 |
| EBITDA | 52 617 | 160 095 | 152 128 | 111 673 | 85 114 | 74 762 | 58 442 |
| Profit before income tax | 32 131 | 141 226 | 138 755 | 94 770 | 62 688 | 45 188 | −21 992 |
| Profit for the reporting year | 32 131 | 141 226 | 138 755 | 94 770 | 62 688 | 45 188 | −21 992 |
| Labour costs | 18 816 | 15 594 | 16 816 | 17 445 | 16 842 | 10 109 | 21 433 |
| Depreciation of non-current assets | 19 350 | 17 325 | 16 548 | 17 407 | 23 852 | 35 725 | 86 413 |
| Other indicators | |||||||
| Employees | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
CompanyPersonShareholderOther roleAdditional link
Related companies
Same activity — Ravimite ja meditsiinikaupade hulgimüük